For nearly 20 years, CutisPharma's singular focus has been to address the needs of patients who are unable to take capsules or tablets, such as children and the elderly, for whom no therapy is commercially available.
Eric Lev is a Partner at Ampersand Capital Partners. Eric has more than 12 years of healthcare investment experience across numerous sectors. Prior to joining Ampersand in 2013, Eric served as a Principal at Water Street Healthcare Partners. Prior to Water Street, Eric worked at Beckman Coulter and One Equity Partners. He has served on the Board of Directors of PLUS Diagnostics, ConVerge Diagnostic Services, and MarketLab. Eric holds a B.A. in Economics from Northwestern University and a M.B.A from the University of Chicago.